Menu
GWAS Study

Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci.

Ellinghaus D, Jostins L, Spain SL et al.

26974007 PubMed ID
GWAS Study Type
86475 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

ED
Ellinghaus D
JL
Jostins L
SS
Spain SL
CA
Cortes A
BJ
Bethune J
HB
Han B
PY
Park YR
RS
Raychaudhuri S
PJ
Pouget JG
HM
Hübenthal M
FT
Folseraas T
WY
Wang Y
ET
Esko T
MA
Metspalu A
WH
Westra HJ
FL
Franke L
PT
Pers TH
WR
Weersma RK
CV
Collij V
DM
D'Amato M
HJ
Halfvarson J
JA
Jensen AB
LW
Lieb W
DF
Degenhardt F
FA
Forstner AJ
HA
Hofmann A
SS
Schreiber S
MU
Mrowietz U
JB
Juran BD
LK
Lazaridis KN
BS
Brunak S
DA
Dale AM
TR
Trembath RC
WS
Weidinger S
WM
Weichenthal M
EE
Ellinghaus E
EJ
Elder JT
BJ
Barker JN
AO
Andreassen OA
MD
McGovern DP
KT
Karlsen TH
BJ
Barrett JC
PM
Parkes M
BM
Brown MA
FA
Franke A
Chapter II

Abstract

Summary of the research findings

We simultaneously investigated the genetic landscape of ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis and ulcerative colitis to investigate pleiotropy and the relationship between these clinically related diseases. Using high-density genotype data from more than 86,000 individuals of European ancestry, we identified 244 independent multidisease signals, including 27 new genome-wide significant susceptibility loci and 3 unreported shared risk loci. Complex pleiotropy was supported when contrasting multidisease signals with expression data sets from human, rat and mouse together with epigenetic and expressed enhancer profiles. The comorbidities among the five immune diseases were best explained by biological pleiotropy rather than heterogeneity (a subgroup of cases genetically identical to those with another disease, possibly owing to diagnostic misclassification, molecular subtypes or excessive comorbidity). In particular, the strong comorbidity between primary sclerosing cholangitis and inflammatory bowel disease is likely the result of a unique disease, which is genetically distinct from classical inflammatory bowel disease phenotypes.

8,726 European ancestry ankylosing spondylitis cases, 19,085 European ancestry Crohn’s disease cases, 6,530 European ancestry psoriasis cases, 3,408 European ancestry primary sclerosing cholangitis cases, 14,513 European ancestry ulcerative colitis cases, 34,213 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

86475
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.S., Australia, New Zealand, Austria, Belgium, France, Germany, Netherlands, Poland, Slovakia, Denmark, Estonia, Finland, Republic of Ireland, Lithuania, Norway, Sweden, U.K., Greece, Italy, Portugal, Spain, Canada
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.